Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: potential for treating Parkinson disease.
about
Anti-cancer activity of new designer hydrogen sulfide-donating hybridsRedox control of microglial function: molecular mechanisms and functional significanceNeuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunityTherapeutic effect of hydrogen sulfide-releasing L-Dopa derivative ACS84 on 6-OHDA-induced Parkinson's disease rat modelA Long-Term and Slow-Releasing Hydrogen Sulfide Donor Protects against Myocardial Ischemia/Reperfusion InjuryDifferential mechanisms underlying neuroprotection of hydrogen sulfide donors against oxidative stress.Evidence of inflammatory system involvement in Parkinson's disease.Role of Hydrogen Sulfide in Ischemia-Reperfusion Injury.Combined effect of hydrogen sulphide donor and losartan in experimental diabetic nephropathy in ratsHydrogen sulfide is a signaling molecule and a cytoprotectant.Hydrogen sulfide in biochemistry and medicine.A novel hydrogen sulfide-releasing N-methyl-D-aspartate receptor antagonist prevents ischemic neuronal deathSulfhydration mediates neuroprotective actions of parkinGlutathione metabolism and Parkinson's disease.Upregulation of cystathionine-β-synthetase expression contributes to inflammatory pain in rat temporomandibular joint.The therapeutic potential of hydrogen sulfide: separating hype from hope.Therapeutic potential of new hydrogen sulfide-releasing hybrids.Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimerasHydrogen sulfide: physiological properties and therapeutic potential in ischaemia.Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases.Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease.New sulfurated derivatives of cinnamic acids and rosmaricine as inhibitors of STAT3 and NF-κB transcription factors.NOSH-aspirin (NBS-1120), a novel nitric oxide and hydrogen sulfide releasing hybrid, attenuates neuroinflammation induced by microglial and astrocytic activation: a new candidate for treatment of neurodegenerative disorders.Toward Hydrogen Sulfide Based Therapeutics: Critical Drug Delivery and Developability Issues.H2S Regulates Hypobaric Hypoxia-Induced Early Glio-Vascular Dysfunction and Neuro-Pathophysiological Effects.Effect of chronic L-dopa or melatonin treatments after dopamine deafferentation in rats: dyskinesia, motor performance, and cytological analysis.High toxicity of hydrogen sulfide by the inhibition of mitochondrial respiration.Age-Dependent, Subunit Specific Action of Hydrogen Sulfide on GluN1/2A and GluN1/2B NMDA Receptors.Regulation of emotional memory by hydrogen sulfide: role of GluN2B-containing NMDA receptor in the amygdala.The dichotomous role of H2S in cancer cell biology? Déjà vu all over again.Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke.Hydrogen sulfide protects blood-brain barrier integrity following cerebral ischemia.Hydrogen sulfide: its production and functionsThe new HS-releasing compound ACS94 exerts protective effects through the modulation of thiol homoeostasis
P2860
Q26825705-DD17761C-28D8-42FB-BE7B-6C929652A7C8Q27000279-175436A4-477B-4658-BC69-8CA786247EE1Q27027973-762737BF-2231-4D53-B45E-06964E11E4CBQ28485947-C0DA375B-16B4-4AEC-BFA5-8F848032725BQ30855744-AD026134-FC05-41C7-8BAB-94FE2A606975Q33692977-E00BA5EA-28A9-4CD9-A003-547220C41B8CQ33890818-3EC679C7-83DA-414C-B5EC-F544886EFDF8Q35647095-9267C50F-CD9A-45C3-BAE7-C9187BEC5431Q35896349-69FE2814-054E-4DA9-B2BC-32134D413C06Q35929049-E838C969-6629-4E2F-8C87-358DD26AD9E8Q35929408-5CA530E8-013C-4690-ACBE-C53AC5D1C913Q36234796-9A956FEC-D78C-4520-B72D-85B571543995Q36756670-A32B9FDB-EC40-4250-ABC3-4D8BCC4A9D9FQ37078480-E8D65174-B4EA-450D-B36A-24337D1F8840Q37567297-469CB2FE-0DEA-44D6-B08B-05357C9782D0Q37872122-3B694393-87CD-4A5C-A80E-8E5490937AD4Q37960619-E82353C7-89E2-450C-8580-5DE95A8C0D07Q38056004-AA85E664-2380-42A8-82B3-8C5F3B768AEFQ38236845-C5DB1C27-482D-4CFA-B0FC-8423BA87A0BFQ38306132-D7121A1F-AFB3-4311-9A87-CBEA90348EDEQ38556918-7ABCCB82-47FC-4C14-9EFF-2A97F33AAFF8Q38696518-9FBA4B2C-BAE9-4C0A-9C89-DF19CC307766Q39114886-48394AB6-8DD8-4AB6-A230-CD4A0BF86C83Q39152370-94E63D34-3B70-4EA6-B060-AE88CB44876DQ39745524-74D99D9D-9587-49DC-8A74-3FB201824440Q42127267-FBBAF2FD-E27D-4B56-9B12-29AA1C9675F2Q42759036-F06D53E6-8E76-4F57-9EBC-A9449C9FE472Q47106415-9AEF7AF9-DE28-4B72-AC80-30B985DD44F8Q47805373-8F9A7361-5030-4B3A-AD2F-72AD4315DCCEQ49346285-E3A17566-C4FB-45B6-8E93-D9209E2BC255Q50203349-12E70DB3-BA43-4BD6-BACB-07B5E76163B3Q50224206-B3EAB22B-8419-4143-8B98-D5777C2294DCQ57120170-6B658488-0F15-4520-A9C5-9A997E55DF01Q58767723-ACE70608-CE18-426F-9372-4C5A793EE4C0
P2860
Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: potential for treating Parkinson disease.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Effects of hydrogen sulfide-re ...... or treating Parkinson disease.
@en
Effects of hydrogen sulfide-re ...... or treating Parkinson disease.
@nl
type
label
Effects of hydrogen sulfide-re ...... or treating Parkinson disease.
@en
Effects of hydrogen sulfide-re ...... or treating Parkinson disease.
@nl
prefLabel
Effects of hydrogen sulfide-re ...... or treating Parkinson disease.
@en
Effects of hydrogen sulfide-re ...... or treating Parkinson disease.
@nl
P2093
P2860
P356
P1476
Effects of hydrogen sulfide-re ...... for treating Parkinson disease
@en
P2093
Edith McGeer
Moonhee Lee
Patrick L McGeer
Piero Del Soldato
Ranieri Rossi
Valerio Tazzari
P2860
P304
17318-17328
P356
10.1074/JBC.M110.115261
P407
P577
2010-04-05T00:00:00Z